SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen O who wrote (955)7/18/2000 7:48:51 PM
From: Edward W. Richmond   of 1321
 
Stephen, if the company meets its profitability target by Q4, I would expect to see a significant appreciation in share price. I don't see either healthcare operations or government agencies blocking access to treatment. In my opinion, public pressure will demand and get this important treatment. In two years, and the possible advent of a competing therapy, I would expect the stock price eclipse anything we have seen in the past.
Just my take on Visudyne.
Regards,
Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News